PA
MBII

Parallel Advisors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Parallel Advisors’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed – – 3657
2022
Q2 		$0 Hold
100
– – ﹤0.01% 3504
2022
Q1 		$0 Hold
100
– – ﹤0.01% 3417
2021
Q4 		$0 Hold
100
– – ﹤0.01% 3413
2021
Q3 		$0 Hold
100
– – ﹤0.01% 3381
2021
Q2 		$0 Buy
+100
New +$167 ﹤0.01% 3137

Parallel Advisors's MBII Position: Q3 2022 in Review

Parallel Advisors sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 100 shares.

Parallel Advisors first reported a position in MBII in Q2 2021 and held it in 5 quarters. The position peaked at $0 in Q2 2022. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

  • Parallel Advisors reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
  • Parallel Advisors sold 100 Marrone Bio Innovations, Inc. shares in Q3 2022.
  • Parallel Advisors first reported a position in Marrone Bio Innovations, Inc. in Q2 2021 and held it in 5 quarters.
  • Parallel Advisors's Marrone Bio Innovations, Inc. position peaked at $0 in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Parallel Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.